Fowler C J, Brännström G
Department of Neuropharmacology, Astra Research Centre AB, Södertälje, Sweden.
J Neurochem. 1990 Jul;55(1):245-50. doi: 10.1111/j.1471-4159.1990.tb08845.x.
The hydrophilic beta-adrenoceptor ligand (-)-[3H]CGP-12177 binds to intact C6 cells with a high affinity (KD approximately 0.1 nM) and with a high degree of specificity. The binding was inhibited by DL-propranolol (Ki approximately 1 nM). Treatment of cells cultured in Dulbecco's modified Eagle medium (DMEM) without fetal calf serum for 4 days with desipramine reduced the (-)-[3H]CGP-12177 specific binding in a concentration-dependent manner, a reduction from 127 to 102 fmol/mg of protein being found at a ligand concentration of 1 nM after treatment with 10 microM desipramine. Lesser effects were seen after treatment for 1 day. A similar result was found with maprotiline, and reductions in specific binding were seen after 4 days of treatment with amitriptyline, iprindole, and citalopram. The reduction in binding-site density (measured per milligram of protein to compensate for variability in cell density per well), however, was paralleled in all cases by a reduction in the rate of cell proliferation. When C6 glioma cells were cultured in Ham's medium without fetal calf serum during the antidepressant treatment period, a higher specific binding was observed than for the DMEM-cultured cells, and 10 microM desipramine was without effect on either the (-)-[3H]CGP-12177 specific binding or cell proliferation. It is concluded that the effects of the antidepressants tested upon the density of (-)-[3H]CGP-12177 specific binding sites in intact C6 cells may be secondary to the toxicity of the compounds under the conditions used.
亲水性β-肾上腺素能受体配体(-)-[3H]CGP - 12177以高亲和力(解离常数KD约为0.1 nM)和高度特异性与完整的C6细胞结合。该结合可被DL-普萘洛尔抑制(抑制常数Ki约为1 nM)。用去甲丙咪嗪处理在不含胎牛血清的杜尔贝科改良伊格尔培养基(DMEM)中培养4天的细胞,(-)-[3H]CGP - 12177特异性结合以浓度依赖方式降低,在用10 μM去甲丙咪嗪处理后,在1 nM配体浓度下,特异性结合从127 fmol/mg蛋白质降至102 fmol/mg蛋白质。处理1天后观察到的影响较小。马普替林也得到类似结果,用阿米替林、茚满丙二胺和西酞普兰处理4天后,特异性结合降低。然而,在所有情况下,结合位点密度的降低(以每毫克蛋白质测量以补偿每孔细胞密度的变异性)与细胞增殖速率的降低平行。当在抗抑郁药处理期间将C6胶质瘤细胞在不含胎牛血清的哈姆培养基中培养时,观察到的特异性结合高于在DMEM中培养的细胞,并且10 μM去甲丙咪嗪对(-)-[3H]CGP - 12177特异性结合或细胞增殖均无影响。得出的结论是,在所使用的条件下,所测试的抗抑郁药对完整C6细胞中(-)-[3H]CGP - 12177特异性结合位点密度的影响可能是这些化合物毒性的继发效应。